新辅助化疗在晚期卵巢癌治疗中的研究进展(4)
[21] Fagotti A， Fanfani F， Vizzielli G， et al. Should laparoscopy be included in the work up of advanced ovarian cancer patients attepting interval debulking surgery[J]. Gynecol Oncol， 2010， 116(1)： 72-77.
[22] Bourdel N，Matsuzaki S，Bazin JE，et al.Postoperative peritoneal dissemination of ovarian cancer cells is not promoted by carbon-dioxide pneumoperitoneum at low intraperitoneal pressure in a syngenic mouse laparoscopic model with controlled respiratory support ： a pilot study[J].J Minim Invasive Gynecol，2008，15(3)：321-326.
[23] Kenp Z ，Ledermann JA.Update on first-line treatment of ovarian carcinoma[J].Womens Health，2013，5：45-51.
[24] Plcher M，Mahner S，Ortmann O，et al.Neoadjuvantchemotherapy with carboplatin and docetaxel in advanced ovarian cancer-a prospective multicenter phase II trial (PRIMOVAR)[J].Oncol Rep，2009，22(3)： 605-613.
[25] Vergote I， Tropé CG， Amant F，et al.Neoadjuvant chemotherapy or primary surgery in Stage IIIc-IV ovarian cancer[J].New Engl Med， 2010(363)：943-953.
[26] Melissa M， Thrall-Heidi J. Gray， et.al.Neoadjuvant chemotherapy in the Medicare cohort with advanced ovarian cancer[J].Gynecol Oncol，2011，123(3)：461-466.
[27] Morrison J， Haldar K， Kehoe S， et al. Chemotherapy versus surgery for initial treatment in advanced ovarian epithelial cancer[J].Cochrane database of systematic reviews (Online)， 2012， 8： CD005343.
(收稿日期：2013-03-28), 百拇医药(郭丽华 胡丽娜)
[22] Bourdel N，Matsuzaki S，Bazin JE，et al.Postoperative peritoneal dissemination of ovarian cancer cells is not promoted by carbon-dioxide pneumoperitoneum at low intraperitoneal pressure in a syngenic mouse laparoscopic model with controlled respiratory support ： a pilot study[J].J Minim Invasive Gynecol，2008，15(3)：321-326.
[23] Kenp Z ，Ledermann JA.Update on first-line treatment of ovarian carcinoma[J].Womens Health，2013，5：45-51.
[24] Plcher M，Mahner S，Ortmann O，et al.Neoadjuvantchemotherapy with carboplatin and docetaxel in advanced ovarian cancer-a prospective multicenter phase II trial (PRIMOVAR)[J].Oncol Rep，2009，22(3)： 605-613.
[25] Vergote I， Tropé CG， Amant F，et al.Neoadjuvant chemotherapy or primary surgery in Stage IIIc-IV ovarian cancer[J].New Engl Med， 2010(363)：943-953.
[26] Melissa M， Thrall-Heidi J. Gray， et.al.Neoadjuvant chemotherapy in the Medicare cohort with advanced ovarian cancer[J].Gynecol Oncol，2011，123(3)：461-466.
[27] Morrison J， Haldar K， Kehoe S， et al. Chemotherapy versus surgery for initial treatment in advanced ovarian epithelial cancer[J].Cochrane database of systematic reviews (Online)， 2012， 8： CD005343.
(收稿日期：2013-03-28), 百拇医药(郭丽华 胡丽娜)